Skip to main content

Table 6 Functional impairment combined for epilepsy and psychosis

From: Evaluation of outcomes for psychosis and epilepsy treatment delivered by primary health care workers in Nepal: a cohort study

  Program Control ANCOVA Full cohort (n = 156) T
Mean (SD) Mean (SD) Effect size
F, partial eta2
P-val* Mean (SD) Effect size
Z, r
P-val**
WHODAS 1.78, 0.01 0.18    7.83, 0.63 < 0.0001
Baseline 39.9 (22.8) 31.2 (23.8)    37.8 (23.2)   
end point 15.4 (21.8) 19.4 (28.7)    16.3 (23.6)   
Δ score − 24.5 (27.8) − 11.8 (33.5)    − 21.5 (29.6)   
BAS      0.01, < 0.01 0.92    10.56, 0.85 < 0.0001
Baseline 74.4 (8.1) 72.2 (9.2)    73.9 (8.4)   
end point 60.4 (6.9) 59.6 (8.1)    60.2 (7.2)   
Δ score − 14.0 (8.8) − 12.6 (10.0)    − 13.7 (9.1)   
  1. WHODAS World Health Organization Disability Assessment Schedule 2.0 Short Version, BAS burden assessment schedule
  2. * P-value taken from ANCOVA (analysis of covariance) for each scale comparing program vs. control scores at end point, adjusted for baseline score
  3. ** P-value from Wilcoxon Signed-Rank Test comparing baseline to end point scores (full cohort)